Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Debbie Mitra"'
Autor:
Kabir Ahluwalia, Juan-Carlos Martinez-Camarillo, Biju B. Thomas, Aditya Naik, Alejandra Gonzalez-Calle, Dimitrios Pollalis, Jane Lebkowski, Sun Young Lee, Debbie Mitra, Stan G. Louie, Mark S. Humayun
Publikováno v:
Cells, Vol 12, Iss 13, p 1689 (2023)
Retinal degenerative diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa, lack effective therapies. Conventional monotherapeutic approaches fail to target the multiple affected pathways in retinal degeneration. However
Externí odkaz:
https://doaj.org/article/dd6e3ad182d5456aaed47f515b086047
Autor:
Britney O. Pennington, Jeffrey K. Bailey, Mohamed A. Faynus, Cassidy Hinman, Mitchell N. Hee, Rory Ritts, Vignesh Nadar, Danhong Zhu, Debbie Mitra, Juan Carlos Martinez-Camarillo, Tai-Chi Lin, Biju B. Thomas, David R. Hinton, Mark S. Humayun, Jane Lebkowski, Lincoln V. Johnson, Dennis O. Clegg
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Age-related macular degeneration (AMD) is the primary cause of blindness in adults over 60 years of age, and clinical trials are currently assessing the therapeutic potential of retinal pigmented epithelial (RPE) cell monolayers on implantab
Externí odkaz:
https://doaj.org/article/f19a0c25861141a083ed1e359e044d22
Autor:
May Griffith, Bo Liedberg, Jaywant Phopase, William. Bruce Jackson, Per Fagerholm, Silvia Odorcic, Kimberley Merrett, Christopher W. Noel, Debbie Mitra, Li Buay Koh, Mohammad Mirazul Islam
Publikováno v:
Journal of Functional Biomaterials, Vol 4, Iss 3, Pp 162-177 (2013)
A bi-functional epoxy-based cross-linker, 1,4-Butanediol diglycidyl ether (BDDGE), was investigated in the fabrication of collagen based corneal substitutes. Two synthetic strategies were explored in the preparation of the cross-linked collagen scaff
Externí odkaz:
https://doaj.org/article/fba7e146434b401a8fd1daf4c068e664
Autor:
Li Buay Koh, Mohammad Mirazul Islam, Debbie Mitra, Christopher W. Noel, Kimberley Merrett, Silvia Odorcic, Per Fagerholm, William Bruce Jackson, Bo Liedberg, Jaywant Phopase, May Griffith
Publikováno v:
Journal of Functional Biomaterials, Vol 5, Iss 1, Pp 27-28 (2014)
It has been brought to our attention very recently that we had an omission error in our methods section of the paper [1]. This is Section 3.4, which should have read as follows.
Externí odkaz:
https://doaj.org/article/97a9352a960d4e3c882815caf31b0676
Autor:
Humayun, Kabir Ahluwalia, Juan-Carlos Martinez-Camarillo, Biju B. Thomas, Aditya Naik, Alejandra Gonzalez-Calle, Dimitrios Pollalis, Jane Lebkowski, Sun Young Lee, Debbie Mitra, Stan G. Louie, Mark S.
Publikováno v:
Cells; Volume 12; Issue 13; Pages: 1689
Retinal degenerative diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa, lack effective therapies. Conventional monotherapeutic approaches fail to target the multiple affected pathways in retinal degeneration. However
Autor:
Mark S. Humayun, Jane Lebkowski, Deepthi S. Rajendran Nair, Jose Miguel Mora Correa, Debbie Mitra, David R. Hinton, Danhong Zhu, Biju B. Thomas, Yuntao Hu, Juan Carlos Martinez Camarillo
Publikováno v:
Journal of visualized experiments : JoVE. (190)
Retinal degeneration, such as age-related macular degeneration (AMD), is a leading cause of blindness worldwide. A myriad of approaches have been undertaken to develop regenerative medicine-based therapies for AMD, including stem cell-based therapies
Autor:
Vignesh P. Nadar, Lincoln V. Johnson, Mark S. Humayun, Dennis O. Clegg, Rory Ritts, Juan Carlos Martinez-Camarillo, Debbie Mitra, Tai-Chi Lin, David R. Hinton, Danhong Zhu, Mitchell N Hee, Cassidy R. Hinman, Britney O Pennington, Biju B. Thomas, Jeffrey K Bailey, Jane Lebkowski, Mohamed A Faynus
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Age-related macular degeneration (AMD) is the primary cause of blindness in adults over 60 years of age, and clinical trials are currently assessing the therapeutic potential of retinal pigmented epithelial (RPE) cell monolayers on implantable scaffo
Autor:
Debbie Mitra, Sanford Chen, Hani Salehi-Had, April Ingram, Chih-Min Lin, Mohamed A Faynus, Lincoln V. Johnson, Mark S. Humayun, Amir H. Kashani, Narsing A. Rao, Jane Lebkowski, Clement Chan, Dennis O. Clegg, Robert L. Avery, Jeffrey K Bailey, Neal V. Palejwala, Cassidy R. Hinman, Sukriti Mohan, David R. Hinton, Wei Dang, Firas M. Rahhal, Britney O Pennington
Publikováno v:
Translational Vision Science & Technology
Purpose To report 1-year follow-up of a phase 1/2a clinical trial testing a composite subretinal implant having polarized human embryonic stem cell (hESC)-derived retinal pigment epithelium (RPE) cells on an ultrathin parylene substrate in subjects w
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
Patients diagnosed with Retinitis Pigmentosa (RP) show, in the advanced stage of the disease, severely restricted peripheral vision causing poor mobility and decline in quality of life. This vision loss causes difficulty identifying obstacles and the
Publikováno v:
Stem Cell Biology and Regenerative Medicine ISBN: 9783030052218
Retinal degenerative diseases, which include age-related macular degeneration and inherited disorders like retinitis pigmentosa, all have some degree of dysfunction and loss of retinal pigmented epithelium (RPE) cells and photoreceptors. Cell therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c28da9e902f6eb5d3e75de995406d18
https://doi.org/10.1007/978-3-030-05222-5_7
https://doi.org/10.1007/978-3-030-05222-5_7